The demand for prescription drugs as a function of cost-sharing.
about
Pharmaceutical policies: effects of cap and co-payment on rational use of medicinesChanges in out-of-pocket payments on utilisation of health care servicesChanges in out-of-pocket payments on utilisation of health care servicesPharmaceutical policies: effects of cap and co-payment on rational drug useAssessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)-study protocol for a 2×2 factorial randomized trial.Determinants of U.S. Prescription Drug Utilization using County Level Data.Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data.The impact of cost sharing on antidepressant use among older adults in British Columbia.Patient compliance with drug therapy for diabetic nephropathyAccess to the morning-after pill in BC.Managing hypertension in patients with renal disease and diabetes.To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.Utilization effects of prescription drug benefits in an aging populationMedicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending.Pharmaceutical cost management and access to psychotropic drugs: the U.S. contextTake-up of Medicare Part D: results from the Health and Retirement Study.Does managed care affect the diffusion of psychotropic medications?Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders.Out-of-pocket expenditure by private households for dental services - empirical evidence from AustriaWhat impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.Program design and long-run costs of a national catastrophic drug insurance plan.Previous Out-of-Pocket Drug Expenditures and Patterns of Antidepressant Use among Workers Receiving Depression-Related Disability Benefits.Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapiesOlder patients' perceptions of medication importance and worth: an exploratory pilot study.Fixed and flexible formularies as cost-control mechanisms.Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget surveyImpact of the phased abolition of co-payments on the utilisation of selected prescription medicines in Wales.Discussing Out-of-Pocket Expenses During Clinical Appointments: An Observational Study of Patient-Psychiatrist Interactions.Primary non-adherence to prescribed medication in general practice: lack of influence of moderate increases in patient copayment.Medication Nonadherence: The Role of Cost, Community, and Individual Factors.Payments, promotion, and the purple pill.Differences in prescription drug use in HMO and self-insured health plans.Patient co-payments and use of prescription medicines.Practitioners and health policy. Case of the Ontario Drug Benefit Plan.Effects of Guideline and Formulary Changes on Statin Prescribing in the Veterans Affairs.Free Medicines Thanks to Retirement: Impact of Coinsurance Exemption on Pharmaceutical Expenditures and Hospitalization Offsets in a national health service.New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on Evaluating Policy Alternatives Rather than Treatment Alternatives.Patient compliance with drug therapy for diabetic nephropathy.Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia
P2860
Q24188009-8E524F89-866F-4240-BA1E-0B8EBB72DB2AQ24234520-ED6C0EFA-D33C-47D8-89E1-0A759BE2D9A5Q24236245-EA72F370-C44F-44A2-BCA2-C32EACE8EEE2Q24242490-46D612FF-19E2-495F-AB3E-2BD39F1883FDQ27301465-290C0CBD-94B7-4DA2-B5B3-B71D206F34A0Q30938662-5BF1351B-B4BE-4F91-90AB-E9E3D3C68166Q33404862-65083C3F-DD97-47D1-9F4C-8669B9A5124CQ33908092-073C714C-13D8-44DD-B87B-A1FC794809CAQ34034845-95694C27-E14C-4E1B-BE6E-1571415D33C4Q34034856-F6ECB358-8CC5-43F8-9E8A-072059CF7AD5Q34034877-93D1E385-EBF2-45DE-BB18-D1B38B30FB6DQ34037255-A554E2A8-9CF1-4005-8F1D-D935B57090D6Q34321762-77BC79CC-CB71-4B3E-9CE7-AC3DEB988452Q34337679-A733145F-98AA-4F1B-A851-39B5A5ECBED7Q34390982-C93B0C1C-72E1-456C-AC93-1248188AF29CQ34400363-84201672-DCA9-4533-A5C7-70ED4D22CA26Q35112617-02FE906A-C461-44A3-8197-787E062450E8Q35291961-0491CEC5-6DA2-48AC-B046-4C2A22A145FEQ35470790-86EAD094-36F2-45EB-A261-B96279076BF6Q36653871-AF141DC0-F7F5-4FD7-8D3A-A1967A4DD50FQ36699426-CD68DFE3-6DD0-404A-AC45-0D6A9D1F44F6Q37103265-7146AC7C-89CB-42F9-8746-8B2BC185E873Q37103463-96CBFDE2-5890-43FE-BD4A-D40B86D807B3Q37229332-E97F94D7-06BD-4F4B-9217-CB95A6D71DECQ37355509-29D21628-E3B4-4BC3-B6C6-6AF79A611515Q37609232-3786709B-0DB7-42AC-966F-735143E0E9BAQ37746867-78DC2C6C-ECCD-47C5-9D6F-105C4F5F1573Q38689751-3A0912FF-56DF-4D7F-9265-1CF4AB454AF8Q38908734-47D7CB17-3FA6-4CB4-8C5D-A511C6FD6EF6Q39242175-9ECB6EC4-8083-4D36-832B-2102D1DCEFD0Q39455827-C202654A-ABFF-49A5-BF59-57586A48243CQ41710021-80D27ED9-D6EC-4870-8743-D02AA855A757Q42608495-EE6743DC-2570-4042-B3E9-1CEC8F712D4DQ42625705-60CEA197-626D-4B1D-82E9-5851131D4B37Q42851309-763F1F9F-FAF6-4E38-BC69-6D2058AF82C5Q45325771-D6B3C816-818B-4B78-9D80-134FFA9F46EAQ50903238-8919C03B-E407-44DA-8F04-09D6DB8BDFC1Q53622322-5ABB1D4B-992C-426F-BCB8-CE047A63ADA1Q55363847-43C3DB1D-5FAB-4DF2-B2B3-F3CB91278016Q57427401-11252CCC-1C58-41BE-97C0-407F41D3FA6C
P2860
The demand for prescription drugs as a function of cost-sharing.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
The demand for prescription drugs as a function of cost-sharing.
@en
The demand for prescription drugs as a function of cost-sharing.
@nl
type
label
The demand for prescription drugs as a function of cost-sharing.
@en
The demand for prescription drugs as a function of cost-sharing.
@nl
prefLabel
The demand for prescription drugs as a function of cost-sharing.
@en
The demand for prescription drugs as a function of cost-sharing.
@nl
P2093
P1476
The demand for prescription drugs as a function of cost-sharing.
@en
P2093
Leibowitz A
Manning WG
Newhouse JP
P304
P356
10.1016/0277-9536(85)90161-3
P407
P577
1985-01-01T00:00:00Z